Evidence map›Paper›PMID 35070957›Full record

ArticleFrontiers in oncology2021

Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy.

Yi-Lun Chen, Chiao-Ling Tsai, Jason Chia-Hsien Cheng, Chun-Wei Wang, Shih-Hung Yang, Yu-Wen Tien, Sung-Hsin Kuo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yi-Lun ChenDivision of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Chiao-Ling TsaiDivision of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Jason Chia-Hsien ChengDivision of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Chun-Wei WangDivision of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Shih-Hung YangCancer Research Center, College of Medicine, National Taiwan University, Taipei, Taiwan.
Yu-Wen TienDepartment of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
Sung-Hsin KuoDivision of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
National Taiwan University Hospital · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe investigated potential factors, including clinicopathological features, treatment modalities, neutrophil-to-lymphocyte ratio (NLR), carbohydrate antigen (CA) 19-9 level, tumor responses correlating with overall survival (OS), local progression (LP), and distant metastases (DMs), in patients with locally advanced pancreatic cancer (LAPC) who received definitive radiotherapy (RT).

methodsWe retrospectively analyzed demographic characteristics; biologically effective doses (BED

resultsA median BED

conclusionOur results indicate that pre-RT NLR and post-RT monitoring of CA19-9 and tumor size reduction can help identify whether patients belong to the good or poor prognostic group of LAPC. The incorporation of new systemic treatments during and after a higher BED

Indexed as

competing riskpancreatic cancerradiotherapyrisk factorssurvival

Identifiers

PMID35070957
PMCPMC8773247
OpenAlexW4205974851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.